Work

Abstract B122: Activity of the novel KIF18A Inhibitor, ATX-295, is enriched in whole genome doubled ovarian and TNBC preclinical models

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-b122

Authors: Laura Ghisolfi, Maureen M. Lynes, April Greene-Colozzi, Livia Shehaj, Brian A. Sparling, Matthew G. Rees, Melissa M. Ronan, Jennifer A. Roth, Inbal Gazy, Stuart Ince, Jason A. Sager, Serena J. Silver

Institutions: Accent Therapeutics (United States), Broad Institute

Language: English

Topic: Microtubule and mitosis dynamics

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415452699

Cites:

Cited by:

Related to: